REVIEW ARTICLE |
|
Year : 2016 | Volume
: 9
| Issue : 3 | Page : 294-299 |
|
Depression in systemic sclerosis: Review of the neuro-immunologic link and pharmacological management
Aditya Somani1, Sujita Kumar Kar1, Jyoti Ranjan Parida2
1 Department of Psychiatry, King George's Medical University, Lucknow, Uttar Pradesh, India 2 Department of Rheumatology, Sanjay Gandhi Post Graduate Institute, Lucknow, Uttar Pradesh, India
Correspondence Address:
Sujita Kumar Kar Department of Psychiatry, King George's Medical University, Lucknow - 226 003, Uttar Pradesh India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/0975-2870.167993
|
|
Depression is a common neuropsychiatric condition associated with systemic sclerosis. The association of depression and systemic sclerosis is the result of multiple mechanisms such as autoimmune, significant morbidity due to multi-system involvement, distorted self-image due to disfigurement, chronic disability, and iatrogenic. The prevalence of depression in systemic sclerosis is as high as 65% as found in several clinical studies. Early diagnosis and appropriate intervention of depression in systemic sclerosis through integrated multidisciplinary team approach is more likely to improve the global outcome of illness. Hence, multidisciplinary management approach is highly recommended for the management of depression in systemic sclerosis. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|